Prof Shahneen Sandhu
Honorary Conjoint Professorial Fellow
The Sir Peter MacCallum Department of Oncology
565 Scholarly works
19 Projects
HIGHLIGHTS
2026
Journal article
Convergent evolution of complex structural variants drives therapy resistance in metastatic prostate cancer
DOI: 10.1186/s13059-026-04074-22026
Journal article
Recurrent intra-tumour heterogeneity is a hallmark of metastatic prostate cancer
DOI: 10.1038/s41467-026-74334-z2026
Journal article
Tumor-resident T cells and dendritic cells form an in situ archetype during immunotherapy response in melanoma
DOI: 10.1038/s41467-026-74076-y2020
Research grants (ARC, NHMRC, MRFF)
Circulating Tumour DNA guidEd Therapy for Stage IIB/C BRAF Mutant Positive mElanoma After surgiCal resecTION (DETECTION)
2019
Research Grant
Up-Front Psma Alliance: Using Theranostics Early to Eradicate Prostate Cancer and Developing Novel Startegies for Psma-Negative Disease
2017
Conference Proceedings
Lutetium-177 PSMA (LuPSMA) theranostics phase II trial: Efficacy, safety and QoL in patients with castrate-resistant prostate cancer treated with LuPSMA
DOI: 10.1093/annonc/mdx370.0022017
Research grants (other domestic)
Novel Approaches for Overcoming Resistance to Therapies for Advanced Melanoma
RECENT SCHOLARLY WORKS
2026
Journal article
Five-year survival with neoadjuvant therapy in melanoma: updated pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC).
DOI: 10.1038/s41591-026-04677-z2026
Journal article
Radiopharmaceutical Combination Therapies in Advanced Prostate Cancer
DOI: 10.2967/jnumed.125.2695272026
Journal article
Tumor-Intrinsic Blood and Imaging Correlatives in Advanced Prostate Cancer Treated with Combination Radiopharmaceutical Therapy and Immunotherapy.
DOI: 10.2967/jnumed.126.2732662026
Journal article
An anti-PMEL antibody−drug conjugate with a Gq/11 inhibitor payload in GNAQ/GNA11-mutant melanomas: a phase 1 trial
DOI: 10.1038/s41591-026-04518-z2026
Journal article
Thrombotic Microangiopathy in Patients Treated with 177Lu-PSMA Combination Therapies
DOI: 10.2967/jnumed.126.2720852026
Journal article
Spatial Profiling Reveals Immune Escape Pathways and Therapeutic Vulnerabilities in Prostate Cancer Bone Metastases
DOI: 10.1158/0008-5472.can-26-23862026
Journal article
Standard neoadjuvant immunotherapy in patients with resectable stage III Melanoma – The early Australian experience
DOI: 10.1016/j.ejca.2026.116865
RECENT PROJECTS
2025
Research grants (ARC, NHMRC, MRFF)
Exploiting Interactions Between Microbiota and T Cells to Improve Melanoma Immunotherapy